December 05, 2013
As providers ready for meaningful use Stage 2 attestation and policymakers start designing Stage 3, CMS announced that the Medicare and Medicaid EHR incentive programs have paid out just shy of $17 billion to spur adoption thus far.
November 26, 2013
As 2013 nears its end and shortly after the final HIPAA Omnibus rule went into effect back in September, many groups are giving the Office of the National Coordinator an earful about implementing the HIPAA Accounting of Disclosures provision.
November 10, 2013
The Health IT Policy Committee, an advisory panel to the federal government, was divided over the start date for Stage 2 meaningful use requirements, voting 12-5 June 8 to delay Stage 2 by one year – from 2013 to 2014.
November 07, 2013
The federal dollars for providers and hospitals attesting to meaningful use keep on coming. But CMS officials say there's been a slight decrease in attestation rates when compared with earlier months.
October 29, 2013
Although meaningful use visionaries are hoping to advance the cause of robust public health registries as part of the program's Stage 3, widespread, seamless public health data exchange still has a ways to go.
October 24, 2013
As HHS Office for Civil Rights finalizes rules for accounting of disclosures as part of the HITECH Act, the Health IT Policy Committee's Privacy and Security Tiger Team is crafting recommendations based on stakeholder input. So far, there are diverging views on the proposed rule.
October 22, 2013
The 16-day government shutdown that ended Oct. 17 brought the work of the Office of the National Coordinator to a screeching halt, with cancelled meetings of high-level federal advisory committees and workgroups. But with the end of the shutdown, all hands are on deck and ready to work, according to ONC officials.
September 24, 2013
mHealth advocates are giving good early reviews to the U.S. Food and Drug Administration's final guidance document on the regulation of mobile medical apps, with one expert calling it "an expansive document that truly seeks to deregulate our nimble and innovative industry, while ensuring patient safety."
September 20, 2013
A Washington D.C. law firm known for its work with mHealth companies is asking the U.S. Food and Drug Administration to "adopt significant fundamental changes to keep pace with medicine and technology."
September 20, 2013
More than 50 patient and consumer organizations are urging the federal government to address population health disparities by ensuring that sexual orientation and gender identity data collection are a focal point of Stage 3 meaningful use.